HAT

A Phase 1 Study of NM32-2668 (Anti ROR1/Anti CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors
Status:

Open

Trial Type:
Esophageal Cancer, Gastric Cancer, Melanoma and Skin Cancers, Ovarian Cancer, Soft Tissue and Bone Cancer

Contact:

Benedito Carneiro, MD
Benedito.carneiro@brownhealth.org

©2025 Brown Cancer Trials